tacrolimus

FDA Drug Profile — Tacrolimus, tacrolimus

tacrolimus is listed in the FDA National Drug Code directory with 10 NDC codes, marketed under brand names including Tacrolimus, tacrolimus. Available dosage forms: ointment, powder, capsule.

Drug details

Generic Name
tacrolimus
Brand Names
Tacrolimus, tacrolimus
Application Number
ANDA200744
Sponsor
E. Fougera & Co. A Division Of Fougera Pharmaceuticals, LLC
NDC Codes
10
Dosage Forms
OINTMENT, POWDER, CAPSULE
Routes
TOPICAL, ORAL
Active Ingredients
TACROLIMUS

Indications and Usage

1 INDICATIONS AND USAGE Tacrolimus capsules are a calcineurin-inhibitor immuno-suppressant indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic liver, kidney, or heart transplants, in combination with other immunosuppressants. ( 1.1 ) 1.1 Prophylaxis of Organ Rejection in Kidney, Liver, or Heart Transplant Tacrolimus capsules are indicated for the prophylaxis of organ rejection, in adult and pediatric patients receiving allogeneic kidney transplant [see Clinical Studies ( 14.1 )], liver transplants [see Clinical Studies ( 14.2 )], or heart transplant [see Clinical Studies ( 14.3 )], in combination with other immunosuppressants.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.